Dr. Lal PathLabs Ltd LALPATHLAB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹1,843.70
- Day Range
- ₹1,801.20–1,854.60
- 52-Week Range
- ₹1,272.60–2,038.60
- Bid/Ask
- ₹1,838.20 / ₹1,842.70
- Shares Outstanding
- 167.21M
- Market Cap
- ₹307.37B
- Volume/Avg
- 119,250 / 346,970
Key Statistics
- Price/Earnings (Normalized)
- 54.77
- Price/Sales
- 10.63
- Dividend Yield (Trailing)
- 0.87%
- Dividend Yield (Forward)
- 1.09%
- Dividend Payment Schedule
- Feb, Nov
- Total Yield
- 0.87%
Company Profile
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the areas of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist in preventing, monitoring, and treating diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 5,611
- Website
- https://www.lalpathlabs.com
Valuation
|
Metric
|
LALPATHLAB
|
|---|---|
Price/Earnings (Normalized) | 54.77 |
Price/Book Value | 12.57 |
Price/Sales | 10.63 |
Price/Cash Flow | 52.42 |
Price/Earnings
LALPATHLAB
Financial Strength
|
Metric
|
LALPATHLAB
|
|---|---|
Quick Ratio | 3.28 |
Current Ratio | 3.48 |
Interest Coverage | 30.37 |
Quick Ratio
LALPATHLAB
Profitability
|
Metric
|
LALPATHLAB
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
LALPATHLAB
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|KcP@s#f | LOCK|$@! | $249B | |||
| Danaher Corp
DHR
| LOCK|N#Gd<h?p | LOCK|X# | $162B | |||
| Agilent Technologies Inc
A
| LOCK|HCSX$<g | LOCK|qj$ | $49B | |||
| IQVIA Holdings Inc
IQV
| LOCK|$lVlT> | LOCK|<<KZM | $46B | |||
| Waters Corp
WAT
| LOCK|KQ%p<@ | LOCK|ZM< | $45B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|?#dW><N | LOCK|?xz | $44B | |||
| Illumina Inc
ILMN
| LOCK|?x<$^M | LOCK|#S>Bz | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|@L$p%^< | LOCK|$!Q@T | $33B | |||
| Quest Diagnostics Inc
DGX
| LOCK|Mw@l#X^ | LOCK|drTSg | $27B | |||
| Labcorp Holdings Inc
LH
| LOCK|&D#@frw | LOCK|N#&Sv | $27B |
United States